Scholars@Duke

Cost-effectiveness of Statin Use Guidelines-Reply.

Publication ,  Journal Article
Pandya, A; Zhu, J; Spahillari, A
Published in: JAMA Cardiol
March 1, 2021
Published version (DOI) Link to item

Duke Scholars

Aferdita Spahillari
Author Aferdita Spahillari Medicine, Cardiology

Published In

JAMA Cardiol

DOI

10.1001/jamacardio.2020.6130

EISSN

2380-6591

Publication Date

March 1, 2021

Volume

6

Issue

3

Start / End Page

364

Location

United States

Related Subject Headings

  • Quality-Adjusted Life Years
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Cost-Benefit Analysis
  • Cholesterol, LDL
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pandya, A., Zhu, J., & Spahillari, A. (2021). Cost-effectiveness of Statin Use Guidelines-Reply. JAMA Cardiol, 6(3), 364. https://doi.org/10.1001/jamacardio.2020.6130
Pandya, Ankur, Jinyi Zhu, and Aferdita Spahillari. “Cost-effectiveness of Statin Use Guidelines-Reply.” JAMA Cardiol 6, no. 3 (March 1, 2021): 364. https://doi.org/10.1001/jamacardio.2020.6130.
Pandya A, Zhu J, Spahillari A. Cost-effectiveness of Statin Use Guidelines-Reply. JAMA Cardiol. 2021 Mar 1;6(3):364.
Pandya, Ankur, et al. “Cost-effectiveness of Statin Use Guidelines-Reply.” JAMA Cardiol, vol. 6, no. 3, Mar. 2021, p. 364. Pubmed, doi:10.1001/jamacardio.2020.6130.
Pandya A, Zhu J, Spahillari A. Cost-effectiveness of Statin Use Guidelines-Reply. JAMA Cardiol. 2021 Mar 1;6(3):364.

Published In

JAMA Cardiol

DOI

10.1001/jamacardio.2020.6130

EISSN

2380-6591

Publication Date

March 1, 2021

Volume

6

Issue

3

Start / End Page

364

Location

United States

Related Subject Headings

  • Quality-Adjusted Life Years
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Cost-Benefit Analysis
  • Cholesterol, LDL
  • 3201 Cardiovascular medicine and haematology